|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yeo TP, Hruban RH, Leach SD, Wilentz RE,
Sohn TA, Kern SE, Iacobuzio-Donahue CA, Maitra A, Goggins M, Canto
MI, et al: Pancreatic cancer. Curr Probl Cancer. 26:176–275. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosenberg L: Pancreatic cancer: A review
of emerging therapies. Drugs. 59:1071–1089. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mittal A, Chitkara D, Behrman SW and
Mahato RI: Efficacy of gemcitabine conjugated and miR-NA-205
complexed micelles for treatment of advanced pancreatic cancer.
Biomaterials. 35:7077–7087. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu J, Liu T, Wang X and He A: Circles
reshaping the RNA world: From waste to treasure. Mol Cancer.
16:582017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Salzman J: Circular RNA expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bonizzato A, Gaffo E, Kronnie Te G and
Bortoluzzi S: CircRNAs in hematopoiesis and hematological
malignancies. Blood Cancer J. 6:e4832016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Yang J, Zhou P, Le Y, Zhou C, Wang
S, Xu D, Lin H and Gong Z: Circular RNAs in cancer: Novel insights
into origins, properties, functions and implications. Am J Cancer
Res. 5:472–480. 2015.PubMed/NCBI
|
|
9
|
Taborda MI, Ramírez S and Bernal G:
Circular RNAs in colorectal cancer: Possible roles in regulation of
cancer cells. World J Gastrointest Oncol. 9:62–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nair AA, Niu N, Tang X, Thompson KJ, Wang
L, Kocher JP, Subramanian S and Kalari KR: Circular RNAs and their
associations with breast cancer subtypes. Oncotarget.
7:80967–80979. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang P, Qiu Z, Jiang Y, Dong L, Yang W, Gu
C, Li G and Zhu Y: Silencing of cZNF292 circular RNA suppresses
human glioma tube formation via the Wnt/β-catenin signaling
pathway. Oncotarget. 7:63449–63455. 2016.PubMed/NCBI
|
|
12
|
Huang M, Zhong Z, Lv M, Shu J, Tian Q and
Chen J: Comprehensive analysis of differentially expressed profiles
of lncRNAs and circRNAs with associated co-expression and ceRNA
networks in bladder carcinoma. Oncotarget. 7:47186–47200.
2016.PubMed/NCBI
|
|
13
|
Ahmed I, Karedath T, Andrews SS, Al-Azwani
IK, Mohamoud YA, Querleu D, Rafii A and Malek JA: Altered
expression pattern of circular RNAs in primary and metastatic sites
of epithelial ovarian carcinoma. Oncotarget. 7:36366–36381. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie H, Ren X, Xin S, Lan X, Lu G, Lin Y,
Yang S, Zeng Z, Liao W, Ding YQ and Liang L: Emerging roles of
circRNA_001569 targeting miR-145 in the proliferation and invasion
of colorectal cancer. Oncotarget. 7:26680–26691. 2016.PubMed/NCBI
|
|
15
|
Fan X, Weng X, Zhao Y, Chen W, Gan T and
Xu D: Circular RNAs in cardiovascular disease: An overview. Biomed
Res Int. 2017:51357812017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Van Rossum D, Verheijen BM and Pasterkamp
RJ: Circular RNAs: Novel regulators of neuronal development. Front
Mol Neurosci. 9:742016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li HM, Hao XK, Wang HM, Liu ZC, He Y, Pu
M, Zhang HT, Yu HC, Duan JL and Qu SB: Circular RNA expression
profile of pancreatic ductal adenocarcinoma revealed by microarray.
Cell Physiol Biochem. 40:1334–1344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin X, Pan YQ, Wang LG, Ma T, Zhang LZ,
Tang AH, Billadeau DD, Wu HS and Huang HJ:
Fructose-1,6-bisphosphatase Inhibits ERK activation and bypasses
gemcitabine resistance in pancreatic cancer by blocking IQGAP1-MAPK
interaction. Cancer Res. 77:4328–4341. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kagawa S, Takano S, Yoshitomi H, Kimura F,
Satoh M, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Furukawa K, et
al: Akt/mTOR signaling pathway is crucial for gemcitabine
resistance induced by Annexin II in pancreatic cancer cell. J Surg
Res. 178:758–767. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qin M, Liu G, Huo X, Tao X, Sun X, Ge Z,
Yang J, Fan J, Liu L and Qin W: Hsa_circ_0001649: A circular RNA
and potential novel biomarker for hepatocellular carcinoma. Cancer
Biomark. 16:161–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang P, Qiu Z, Jiang Y, Dong L, Yang WS,
Gu C, Li G and Zhu Y: Silencing of cZNF292 circular RNA suppresses
human glioma tube formation via the Wnt/β-catenin
signaling pathway. Oncotarget. 7:63449–63455. 2016.PubMed/NCBI
|
|
24
|
Zhong Z, Lv M and Chen J: Screening
differential circular RNA expression profiles reveals the
regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in
bladder carcinoma. Sci Rep. 6:309192016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang W, Du WW, Li X, Yee AJ and Yang BB:
Foxo3 activity promoted by non-coding effects of circular RNA and
Foxo3 pseudogene in the inhibition of tumor growth and
angiogenesis. Oncogene. 35:3919–3931. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li F, Zhang L, Li W, Deng J, Zheng J, An
M, Lu J and Zhou Y: Circular RNA ITCH has inhibitory effect on ESCC
by suppressing the Wnt/β-catenin pathway. Oncotarget. 6:6001–6013.
2015.PubMed/NCBI
|
|
27
|
Zhang Y, Zhang XO, Chen T, Xiang JF, Yin
QF, Xing YH, Zhu S, Yang L and Chen LL: Circular intronic long
noncoding RNAs. Mol Cell. 51:792–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sui X, Kong N, Ye L, Han W, Zhou J, Zhang
Q, He C and Pan H: p38 and JNK MAPK pathways control the balance of
apoptosis and autophagy in response to chemotherapeutic agents.
Cancer Lett. 344:174–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kagawa S, Takano S, Yoshitomi H, Kimura F,
Satoh M, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Furukawa K, et
al: Akt/mTOR signaling pathway is crucial for gemcitabine
resistance induced by Annexin II in pancreatic cancer cells. J Surg
Res. 178:758–767. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang K, Long B, Liu F, Wang JX, Liu CY,
Zhao B, Zhou LY, Sun T, Wang M, Yu T, et al: A circular RNA
protects the heart from pathological hypertrophy and heart failure
by targeting miR-223. Eur Heart J. 37:2602–2611. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peng L, Zhu H, Wang J, Sui H, Zhang H, Jin
C, Li L, Xu T and Miao R: MiR-492 is functionally involved in
Oxaliplatin resistance in colon cancer cells LS174T via its
regulating the expression of CD147. Mol Cell Biochem. 405:73–79.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hwang JH, Voortman J, Giovannetti E,
Steinberg SM, Leon LG, Kim YT, Funel N, Park JK, Kim MA, Kang GH,
et al: Identification of microRNA-21 as a biomarker for
chemoresistance and clinical outcome following adjuvant therapy in
resectable pancreatic cancer. PLoS One. 5:e106302010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong J, Zhao Y, Zhou L, Zhang TP and Chen
G: Bcl-2 upregulation induced by miR-21 via a direct interaction is
associated with apoptosis and chemoresistance in MIA PaCa-2
pancreatic cancer cells. Arch Med Res. 42:8–14. 2011. View Article : Google Scholar : PubMed/NCBI
|
